FDA is collaborating with patients, members of academia, and the pharmaceutical industry to encourage the development of new treatments for sickle cell disease (SCD).
via FDA Consumer Health Information Updates http://ift.tt/1r2Tene
via FDA Consumer Health Information Updates http://ift.tt/1r2Tene
No comments:
Post a Comment